Compared with the healthy control, the ratio of CD3+, CD3+CD4+, and NK cells was decreased in the T lymphocytes in the peripheral blood of patients with late-stage NSCLC (P < 0.05, Table 2). The gene discussed is CD4; the disease is non-small cell lung carcinoma.